Page last updated: 2024-09-05

sb 203580 and amiloride

sb 203580 has been researched along with amiloride in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(amiloride)
Trials
(amiloride)
Recent Studies (post-2010) (amiloride)
3,48941,1377,584339788

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)amiloride (IC50)
Urokinase-type plasminogen activatorHomo sapiens (human)4.7
Urokinase-type plasminogen activatorMus musculus (house mouse)2.3
Amine oxidase [flavin-containing] AHomo sapiens (human)3.909
Sodium/hydrogen exchanger 1Rattus norvegicus (Norway rat)1
Amiloride-sensitive sodium channel subunit alphaHomo sapiens (human)0.776
Sodium/hydrogen exchanger 2Oryctolagus cuniculus (rabbit)1
Acid-sensing ion channel 3Homo sapiens (human)4.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Loubat, A; Ponzio, G; Rochet, N; Rossi, B; Turchi, L1

Other Studies

1 other study(ies) available for sb 203580 and amiloride

ArticleYear
Evidence for a direct correlation between c-Jun NH2 terminal kinase 1 activation, cyclin D2 expression, and G(1)/S phase transition in the murine hybridoma 7TD1 cells.
    Experimental cell research, 2000, Nov-25, Volume: 261, Issue:1

    Topics: Amiloride; Animals; Cell Cycle; Cyclin D2; Cyclins; Enzyme Activation; Enzyme Inhibitors; Ethylamines; G1 Phase; Humans; Hybridomas; Imidazoles; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyridines; Recombinant Proteins; S Phase

2000